Zimmer Biomet Company Top Insiders

ZBH Stock  USD 110.73  1.05  0.94%   
Zimmer Biomet employs about 17 K people. The company is managed by 35 executives with a total tenure of roughly 203 years, averaging almost 5.0 years of service per executive, having 485.71 employees per reported executive. Assessment of Zimmer Biomet's management performance can provide insight into the firm performance.
Larry Glasscock  Chairman
Independent Non-Executive Chairman of the Board
Bryan Hanson  Chairman
Chairman of the Board, President, Chief Executive Officer
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Zimmer Biomet's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Zimmer Biomet's future performance. Based on our forecasts, it is anticipated that Zimmer will maintain a workforce of under 17000 employees by April 2025.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Zimmer Biomet's latest congressional trading

Congressional trading in companies like Zimmer Biomet Holdings, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Zimmer Biomet by those in governmental positions are based on the same information available to the general public.
2025-03-13Representative Julie JohnsonAcquired Under $15KVerify
2024-12-06Representative Ro KhannaAcquired Under $15KVerify
2017-01-04Senator John ReedAcquired Under $15KVerify

Zimmer Biomet Management Team Effectiveness

The company has Return on Asset of 0.0465 % which means that on every $100 spent on assets, it made $0.0465 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0725 %, implying that it generated $0.0725 on every 100 dollars invested. Zimmer Biomet's management efficiency ratios could be used to measure how well Zimmer Biomet manages its routine affairs as well as how well it operates its assets and liabilities. The Zimmer Biomet's current Return On Tangible Assets is estimated to increase to 0.17, while Return On Capital Employed is projected to decrease to 0.06. As of now, Zimmer Biomet's Asset Turnover is decreasing as compared to previous years.
100%
The current Common Stock Shares Outstanding is estimated to decrease to about 164.9 M. The current Net Income Applicable To Common Shares is estimated to decrease to about 252.8 M

Zimmer Biomet Workforce Comparison

Zimmer Biomet Holdings is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 406,293. Zimmer Biomet holds roughly 17,000 in number of employees claiming about 4% of equities under Health Care industry.
JavaScript chart by amCharts 3.21.15OthersBSXMDTABTSNNUFZBH

Zimmer Biomet Profit Margins

The company has Net Profit Margin of 0.12 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.23 %, which entails that for every 100 dollars of revenue, it generated $0.23 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.80.7146
Moderately Up
Pretty Stable
Operating Profit Margin0.220.1674
Significantly Up
Slightly volatile

Zimmer Biomet Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zimmer Biomet insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zimmer Biomet's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Zimmer Biomet insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
0.8542
41
48
 378,340 
 217,534 
2024-12-01
5.5
11
2
 34,148 
 23,045 
2024-09-01
5.0
10
2
 4,843 
 3,190 
2024-06-01
6.2
31
5
 18,766 
 14,668 
2024-03-01
0.975
39
40
 194,901 
 134,290 
2023-12-01
1.0
10
10
 4,346 
 54,956 
2023-09-01
6.6667
20
3
 31,806 
 8,078 
2023-06-01
15.0
30
2
 15,737 
 825.00 
2023-03-01
1.625
26
16
 162,668 
 83,458 
2022-12-01
1.8571
13
7
 17,129 
 26,399 
2022-09-01
2.5
10
4
 6,105 
 8,181 
2022-06-01
15.5
31
2
 22,869 
 698.00 
2022-03-01
9.75
39
4
 467,147 
 64,913 
2021-12-01
0.4839
15
31
 64,115 
 200,119 
2021-09-01
6.0
12
2
 55,755 
 4,767 
2021-06-01
10.0
30
3
 18,583 
 1,677 
2021-03-01
1.5789
30
19
 288,100 
 46,869 
2020-12-01
1.1538
15
13
 44,019 
 79,541 
2020-09-01
3.6667
11
3
 7,069 
 6,288 
2020-06-01
15.5
31
2
 25,622 
 9,717 
2020-03-01
2.3571
33
14
 391,443 
 47,148 
2019-12-01
1.1111
20
18
 32,522 
 48,096 
2019-09-01
1.8571
13
7
 114,086 
 74,745 
2019-06-01
7.5
30
4
 25,796 
 11,639 
2019-03-01
3.5385
46
13
 365,528 
 22,627 
2018-12-01
8.0
16
2
 65,078 
 12,622 
2018-09-01
2.1429
15
7
 61,162 
 71,701 
2018-06-01
3.7143
26
7
 31,431 
 20,582 
2018-03-01
5.8333
35
6
 588,586 
 48,557 
2017-12-01
1.8571
13
7
 339,212 
 25,762 
2017-09-01
1.5556
14
9
 26,361 
 33,282 
2017-06-01
1.7619
37
21
 174,048 
 283,208 
2017-03-01
1.6818
37
22
 523,484 
 270,163 
2016-12-01
5.0
10
2
 6,975 
 10,100 
2016-09-01
0.9167
11
12
 19,968 
 66,618 
2016-06-01
3.0909
34
11
 23,585 
 50,622 
2016-03-01
1.5714
33
21
 574,565 
 40,720,036 
2015-12-01
2.25
9
4
 6,733 
 10,844 
2015-06-01
1.0385
54
52
 798,845 
 209,284 
2015-03-01
1.1429
24
21
 170,302 
 139,375 
2014-12-01
0.875
14
16
 91,430 
 138,016 
2014-09-01
1.6667
10
6
 82,642 
 92,473 

Zimmer Biomet Notable Stakeholders

A Zimmer Biomet stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Zimmer Biomet often face trade-offs trying to please all of them. Zimmer Biomet's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Zimmer Biomet's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Larry GlasscockIndependent Non-Executive Chairman of the BoardProfile
Bryan HansonChairman of the Board, President, Chief Executive OfficerProfile
Ellison HumphreySenior Vice President, Chief Transformation OfficerProfile
Derek DavisChief Accounting Officer, Vice President, ControllerProfile
Ivan TornosGroup President - Global Businesses and AmericasProfile
Suketu UpadhyayChief Financial Officer, Executive Vice PresidentProfile
Sang YiPresident Asia PacificProfile
Chad PhippsSenior Vice President, General Counsel, SecretaryProfile
Arthur HigginsIndependent DirectorProfile
Michael MichelsonIndependent DirectorProfile
Christopher BegleyLead Independent DirectorProfile
Betsy BernardIndependent DirectorProfile
Maria HiladoIndependent DirectorProfile
Syed JafryIndependent DirectorProfile
Michael FarrellIndependent DirectorProfile
Zachary CPADirector RelationsProfile
Gail BoudreauxIndependent DirectorProfile
Robert HagemannIndependent DirectorProfile
Chad JDGeneral VPProfile
Angela MainGlobal VPProfile
Sreelakshmi KolliIndependent DirectorProfile
Didier DeltortPresident - Europe, Middle East and AfricaProfile
Carrie NicholChief Accounting Officer, Vice President ControllerProfile
Kenneth TrippSenior LogisticsProfile
Nitin GoyalChief Science, Technology and Innovation OfficerProfile
Wilfred ZuilenPresident - Europe, Middle East and AfricaProfile
Zeeshan TariqSenior OfficerProfile
Keri MattoxSenior Vice President - Investor Relations, Chief Communications OfficerProfile
Rachel EllingsonSenior Vice President Chief Strategy Officer, Executive OfficerProfile
Kristen CardilloSenior OfficerProfile
Nitin MDTechnology ScienceProfile
Paul StellatoController VPProfile
Lori WinklerChief Human Resource Officer, Senior Vice PresidentProfile
David DeMartinoSenior RelationsProfile
Shaun BraunSenior OfficerProfile

About Zimmer Biomet Management Performance

The success or failure of an entity such as Zimmer Biomet Holdings often depends on how effective the management is. Zimmer Biomet management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Zimmer management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Zimmer management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.12  0.17 
Return On Capital Employed 0.07  0.06 
Return On Assets 0.04  0.04 
Return On Equity 0.07  0.07 

Zimmer Biomet Workforce Analysis

Traditionally, organizations such as Zimmer Biomet use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Zimmer Biomet within its industry.

Zimmer Biomet Manpower Efficiency

Return on Zimmer Biomet Manpower

Revenue Per Employee451.7K
Revenue Per Executive219.4M
Net Income Per Employee26.6K
Net Income Per Executive12.9M
Working Capital Per Employee130.6K
Working Capital Per Executive63.4M

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios